Abstract:Transforming growth factor beta (TGF beta) is a secreted growth and differentiation factor that influences vital cellular processes like proliferation, adhesion, motility, and apoptosis. Regulation of the TGF beta signaling pathway is of key importance to maintain tissue homeostasis. Perturbation of this signaling pathway has been implicated in a plethora of diseases, including cancer. The effect of TGF beta is dependent on cellular context, and TGF beta can perform both anti- and pro-oncogenic roles. TGF beta acts by binding to specific cell surface TGF beta type I and type II transmembrane receptors that are endowed with serine/threonine kinase activity. Upon ligand-induced receptor phosphorylation, SMAD proteins and other intracellular effectors become activated and mediate biological responses. The levels, localization, and function of TGF beta signaling mediators, regulators, and effectors are highly dynamic and regulated by a myriad of post-translational modifications. One such crucial modification is ubiquitination. The ubiquitin modification is also a mechanism by which crosstalk with other signaling pathways is achieved. Crucial effector components of the ubiquitination cascade include the very diverse family of E3 ubiquitin ligases. This review summarizes the diverse roles of E3 ligases that act on TGF beta receptor and intracellular signaling components. E3 ligases regulate TGF beta signaling both positively and negatively by regulating degradation of receptors and various signaling intermediates. We also highlight the function of E3 ligases in connection with TGF beta's dual role during tumorigenesis. We conclude with a perspective on the emerging possibility of defining E3 ligases as drug targets and how they may be used to selectively target TGF beta-induced pro-oncogenic responses.

Regulatory Role of E3 Ubiquitin Ligases in Normal B Lymphopoiesis and B-cell Malignancies.

Cullin-RING ligases in regulation of autophagy

The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

Targeting the ubiquitin pathway in lymphoid malignancies

Ubiquitin ligases and the immune response.

Immune regulation by protein ubiquitination: roles of the E3 ligases VHL and Itch

E3 ubiquitin ligase on the biological properties of hematopoietic stem cell

The Role Of Ubiquitinase In B Cell Development And Function

E3 ubiquitin ligases as cancer targets and biomarkers.

Multifaceted Roles of the E3 Ubiquitin Ligase RING Finger Protein 115 in Immunity and Diseases

The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disorders

E3 Ligase C-Cbl Mediates Ubiquitination-Proteasomal Degradation Of Bcr-Abl And Therapeutic Effects Against Bcr-Abl Leukemia

The role of CBL family ubiquitin ligases in cancer progression and therapeutic strategies

Regulation of T Cell Differentiation and Function by Ubiquitin-Specific Proteases.

Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer

E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression

Exploiting E3 ubiquitin ligases to reeducate the tumor microenvironment for cancer therapy

E3 Ubiquitin Ligases: Key Regulators of TGF Signaling in Cancer Progression

E3 ubiquitin ligase WWP2 as a promising therapeutic target for diverse human diseases

The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer

Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy